High Levels of Are Associated with the Pathogenesis of Parkinson's Disease

Overview

Journal Front Integr Neurosci

Date 2023 Jan 23

PMID 36686268

Authors

ShuJia Zuo

Haijing Wang

Qiang Zhao

Jie Tang

Min Wang

Yu Zhang

Ming Sang

Jing Tian

Puqing Wang

Affiliations

Soon will be listed here.

Abstract

Background: The diagnosis of Parkinson's disease (PD) is complex and there are no biomarkers for early identification. Many studies have reported altered gut microbiota in patients with PD compared with healthy individuals. However, results from previous studies vary across countries.

Aims: The aim of this study was to identify gut microbiota biomarkers that could be used as a marker for the diagnosis of PD.

Methods: Firstly, the differential gut microbiota was obtained by meta-analysis, and then the results of meta-analysis were validated through metagenomic cohort. Finally, the ROC curve was drawn based on the metagenomic validation results.

Results: The meta-analysis showed a lower relative abundance of ( < 0.00001) and ( = 0.002), and a higher of ( < 0.00001), ( = 0.03), ( < 0.00001), and ( = 0.02) in patients with PD. Only was also at high levels in the validation cohort of the metagenome. Meanwhile, three species from the , including ( = 0.022), ( = 0.005), and ( = 0.024) were also high. The ROC curve showed that the three species (71.2%) from had good predictive efficiency for PD.

Conclusion: Elevated may be associated with PD. Elevated three species from the , including , and may provide new potential biomarkers for the diagnosis of PD.

Citing Articles

A Mix of Potentially Probiotic Strains Alters the Gut Microbiota in a Dose- and Sex-Dependent Manner in Wistar Rats.

Carneiro Dos Santos L, Carvalho R, Cruz Neto J, de Albuquerque Lemos D, de Oliveira K, Sampaio K Microorganisms. 2024; 12(4).

PMID: 38674604 PMC: 11052373. DOI: 10.3390/microorganisms12040659.

Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.

Liu X, Liu Y, Liu J, Zhang H, Shan C, Guo Y Neural Regen Res. 2023; 19(4):833-845.

PMID: 37843219 PMC: 10664138. DOI: 10.4103/1673-5374.382223.

References

Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J . Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease. Neurosci Lett. 2019; 707:134297. DOI: 10.1016/j.neulet.2019.134297. View

Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B . Parkinson's disease biomarkers based on α-synuclein. J Neurochem. 2019; 150(5):626-636. DOI: 10.1111/jnc.14809. View

Cryan J, Dinan T . Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10):701-12. DOI: 10.1038/nrn3346. View

Li W, Wu X, Hu X, Wang T, Liang S, Duan Y . Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features. Sci China Life Sci. 2017; 60(11):1223-1233. DOI: 10.1007/s11427-016-9001-4. View

Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K . Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease. PLoS One. 2015; 10(11):e0142164. PMC: 4634857. DOI: 10.1371/journal.pone.0142164. View

Luck B, Horvath T, Engevik K, Ruan W, Haidacher S, Hoch K . Neurotransmitter Profiles Are Altered in the Gut and Brain of Mice Mono-Associated with . Biomolecules. 2021; 11(8). PMC: 8392031. DOI: 10.3390/biom11081091. View

Siucinska E . Γ-Aminobutyric acid in adult brain: an update. Behav Brain Res. 2019; 376:112224. DOI: 10.1016/j.bbr.2019.112224. View

Stang A, Poole C, Kuss O . The ongoing tyranny of statistical significance testing in biomedical research. Eur J Epidemiol. 2010; 25(4):225-30. DOI: 10.1007/s10654-010-9440-x. View

Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J . Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China. Front Mol Neurosci. 2019; 12:171. PMC: 6637281. DOI: 10.3389/fnmol.2019.00171. View

10.

Tan A, Chong C, Lim S, Yap I, Teh C, Loke M . Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics. Ann Neurol. 2020; 89(3):546-559. DOI: 10.1002/ana.25982. View

11.

Lin A, Zheng W, He Y, Tang W, Wei X, He R . Gut microbiota in patients with Parkinson's disease in southern China. Parkinsonism Relat Disord. 2018; 53:82-88. DOI: 10.1016/j.parkreldis.2018.05.007. View

12.

Shi L, Huang C, Luo Q, Rogers E, Xia Y, Liu W . The Association of Iron and the Pathologies of Parkinson's Diseases in MPTP/MPP-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture. Front Aging Neurosci. 2019; 11:215. PMC: 6729105. DOI: 10.3389/fnagi.2019.00215. View

13.

Su D, Yang S, Hu W, Wang D, Kou W, Liu Z . The Characteristics of Tremor Motion Help Identify Parkinson's Disease and Multiple System Atrophy. Front Neurol. 2020; 11:540. PMC: 7366128. DOI: 10.3389/fneur.2020.00540. View

14.

Sankowski B, Ksiezarczyk K, Rackowska E, Szlufik S, Koziorowski D, Giebultowicz J . Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease. Clin Chim Acta. 2019; 501:165-173. DOI: 10.1016/j.cca.2019.10.038. View

15.

Elfil M, Kamel S, Kandil M, Koo B, Schaefer S . Implications of the Gut Microbiome in Parkinson's Disease. Mov Disord. 2020; 35(6):921-933. DOI: 10.1002/mds.28004. View

16.

Ren T, Gao Y, Qiu Y, Jiang S, Zhang Q, Zhang J . Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease. Front Neurol. 2020; 11:137. PMC: 7052381. DOI: 10.3389/fneur.2020.00137. View

17.

Li J, Jin M, Wang L, Qin B, Wang K . MDS clinical diagnostic criteria for Parkinson's disease in China. J Neurol. 2016; 264(3):476-481. DOI: 10.1007/s00415-016-8370-2. View

18.

Choi J, Kim N, Ju I, Eo H, Lim S, Jang S . Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice. Sci Rep. 2018; 8(1):1275. PMC: 5775305. DOI: 10.1038/s41598-018-19646-x. View

19.

Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S . Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. Mov Disord. 2018; 34(3):396-405. DOI: 10.1002/mds.27581. View

20.

Asgharian M, Gholizadeh P, Kafil H, Ghojazadeh M, Samadi A, Soleymani J . Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease. Adv Med Sci. 2022; 67(2):304-310. DOI: 10.1016/j.advms.2022.07.004. View